Corbus Pharmaceuticals
CRBP
CRBP
111 hedge funds and large institutions have $185M invested in Corbus Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 44 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 105 → 111 (+6)
0.04% more ownership
Funds ownership: 1.59% → 1.62% (+0.04%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
111
Holding in Top 10
1
Calls
$6.89M
Puts
$2.05M
Top Buyers
| 1 | +$7.14M | |
| 2 | +$6.41M | |
| 3 | +$3.83M | |
| 4 |
D.E. Shaw & Co
New York
|
+$3.02M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.76M |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$1.47M | |
| 3 | -$635K | |
| 4 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$340K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$314K |